Spectrum Chemical Launches bioCERTIFIED™ Cleaning in Place Solutions

0
326
Spectrum Chemical bioCERTIFIED™ product.

GARDENA, Calif.– Spectrum Chemical Mfg. Corp., a leading global manufacturer and distributor of fine chemicals, laboratory equipment and supplies, will introduce its new bioCERTIFIED™ Cleaning in Place (CIP) high purity solutions at the BioProcess International Conference in Boston.

The new line of CIP products is part of the company’s growing bioCERTIFIED quality management system and chemicals portfolio, which feature expanded laboratory testing, certifications and documentation to meet stringent quality standards and regulatory requirements of biopharmaceutical manufacturers.

Spectrum Chemical’s bioCERTIFIED CIP solutions help prevent contamination of costly media and filtration equipment by sterilizing and removing residue. The high purity solutions are designed to:

  • Speed production time and eliminate cross-batch contamination
  • Employ consistent hygiene standards to ensure quality
  • Lower labor costs associated with manual cleaning
  • Reduce exposure risk to personnel by using fewer chemicals
  • Provide complete documentation and access to technical support to ensure regulatory compliance

Randy Burg, Spectrum Chemical President and CEO, said, “Biopharmaceutical manufacturers can achieve a higher level of cleaning efficiency and safety in critical areas with our bioCERTIFIED Cleaning in Place solutions. Our unique blend of chemicals boasts new standards of purity and are uniquely designed to remove residue without the need to disassemble equipment.”

Backed by Spectrum Chemical’s “100% Tested and 100% Transparent” guarantee, the company’s bioCERTIFIED™ quality program and chemicals undergo stringent in-house testing in cGMP-compliant facilities. This includes additional testing for bioburden, endotoxin and elemental impurities to ensure product purity. Additionally, documented change controls and sourcing ensure fully supply chain transparency backed by an industry-leading support team to help manufacturers reduce their workload so they can focus on accelerating biopharmaceutical production.